Mela Sciences Inc Com (NASDAQ:MELA)

CAPS Rating: 1 out of 5

A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.


Player Avatar pchop123 (80.37) Submitted: 12/10/2012 4:24:38 PM : Underperform Start Price: $21.30 MELA Score: +5.39

likely to be light in the revenue catagory short term

Featured Broker Partners